DVHGF (Devonian Health Group) 9-Day RSI: 0.01 (As of Jul. 12, 2026)


DVHGF Devonian Health Group Inc DVHGF
49 GF Score
Price $7.00
GF Value $1.94
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Devonian Health Group 9-Day RSI?

Devonian Health Group DVHGF 49 9-Day RSI is 0.01 as of Jul. 12, 2026. GuruFocus rates DVHGF with a GF Score™ of 49/100 and a GF Value™ of $1.94 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,421 Biotechnology companies, Devonian Health Group ranks worse than 63.27% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-12), Devonian Health Group's 9-Day RSI is 0.01.

The industry rank for Devonian Health Group's 9-Day RSI or its related term are showing as below:

DVHGF's 9-Day RSI is ranked worse than
63.27% of 1421 companies
in the Biotechnology industry
Industry Median: 49.68 vs DVHGF: 0.01

Devonian Health Group  (OTCPK:DVHGF) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Devonian Health Group 9-Day RSI Related Terms


DVHGF vs VRTX, REGN, ALNY: 9-Day RSI Comparison

For the Biotechnology subindustry, Devonian Health Group's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's 9-Day RSI falls into.


DVHGF
49GF Score
Devonian Health Group Inc DVHGF
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devonian Health Group  (OTCPK:DVHGF) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 0.01 mean?
Devonian Health Group (DVHGF) has a 9-Day RSI of 0.01 as of Jul. 12, 2026. According to the industry distribution chart, Devonian Health Group ranks #899 out of 1421 companies in the Biotechnology industry, placing it in the top 63.3%.
Is Devonian Health Group's 9-Day RSI too high?
Devonian Health Group's current 9-Day RSI is 0.01. The Biotechnology industry median 9-Day RSI is 49.68. Devonian Health Group's value of 0.01 is 100% below this industry median. Based on the distribution chart, Devonian Health Group ranks #899 out of 1421 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Devonian Health Group has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's 9-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Devonian Health Group ranks #899 out of 1421 companies for 9-Day RSI. This places Devonian Health Group in the lower half of its industry. The industry median 9-Day RSI is 49.68. Devonian Health Group's value of 0.01 is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Biotechnology company?
The median 9-Day RSI among Biotechnology companies is 49.68, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Devonian Health Group's current 9-Day RSI of 0.01 is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 9-Day RSI is 49.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devonian Health Group's current 9-Day RSI is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Based on GuruFocus' analysis, Devonian Health Group (DVHGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.94, compared to a current price of $7.00 — trading 260.8% above its estimated fair value. The current 9-Day RSI is 0.01 and 100% below the Biotechnology industry median of 49.68. Devonian Health Group's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current 9-Day RSI is 0.01 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devonian Health Group (DVHGF) Overvalued in 2026?

Based on GuruFocus' analysis, Devonian Health Group stock appears to be overvalued. The current stock price of $7.00 is trading 260.8% above its estimated GF Value™ of $1.94. GuruFocus considers Devonian Health Group to be Significantly Overvalued.

Key valuation signals for DVHGF:

  • 9-Day RSI: 0.01
  • GF Value™: $1.94 vs. price of $7.00 (260.8% above fair value)
  • GF Score™: 49/100 with 7 warning signs
  • Industry Position: 100% below the Biotechnology median (#899 of 1421)

No single metric tells the full story. See the DVHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Devonian Health Group Business Description

Other Exchanges GSD:Canada
Address 360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
49GF Score

Get the complete analysis for DVHGF

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.00
Price
$1.94
GF Value